Your browser doesn't support javascript.
loading
Interaction of High- and Low-Risk Human Papillomavirus Genotypes is Associated with a Reduced Risk of Developing Cervical Cancer.
Hasanzadeh, Malihe; Rejali, Marzieh; Khalili-Tanha, Ghazaleh; Mehramiz, Mehraneh; Yavari, Negar; Nazari, Elham; Malakuti, Parnian; Maleki, Faezeh; Ghorbannezhad, Ghazale; Rafiei, Mahdi; Mirani, Anahita; Gholampoor-Shamkani, Negar; Saber, Hoda; Mousavi Seresht, Leila; Emamdadi-Aliabad, Zohreh; Mahdian, Zahra; Akbari, Mahdieh; Ferns, Gordon A; Al Moustafa, Ala-Eddin; Avan, Amir.
Afiliação
  • Hasanzadeh M; Department of Gynecology Oncology, Woman Health Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Rejali M; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Khalili-Tanha G; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Mehramiz M; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Yavari N; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Nazari E; Basic Medical Sciences Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Malakuti P; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Maleki F; Basic Medical Sciences Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Ghorbannezhad G; Medical Student, Faculty of Medicine, Szeged university of medical sciences, Szeged,Hungary.
  • Rafiei M; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Mirani A; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Gholampoor-Shamkani N; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Saber H; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Mousavi Seresht L; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Emamdadi-Aliabad Z; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Mahdian Z; Basic Medical Sciences Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Akbari M; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Ferns GA; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Al Moustafa AE; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Avan A; Brighton & Sussex Medical School, Division of Medical Education, Falmer, Brighton, Sussex, UK.
Article em En | MEDLINE | ID: mdl-39313887
ABSTRACT

INTRODUCTION:

Cervical cancer is among the most common types of cancer in women and is associated with human papillomavirus (HPV) infection. The association between cervical cancer and high-risk HPV infection has been well documented. However, the effect of simultaneous infection with high- and low-risk HPV or low-risk HPV alone on the risk of developing cervical malignancy remains unanswered in guidelines.

METHOD:

We investigated the association of high and low-risk HPVs (HR or LR) genotypes with cervical carcinoma risk and pathological and cytological information in cases recruited from a population-based cohort study of 790 patients. Correlation matrix and t-test were used for analysis.

RESULTS:

The percentage of HR+LR and HR-HPV16/18 were 9.30% and 11.20% in class II, 7.15% and 7.10% in class IV, and 7.15% and 5.80% in As-CUS smears. Interestingly, concurrent infection with HR-HPV and LR-HPV types led to a significant reduction in the risk of developing malignancy compared to the high-risk group (OR=0.3 (0.098-0.925), pvalue=0.04). The percentage of individuals with cervical malignancy was 10.2% and 28.2% within the co-infected and the HR-HPV participants.

CONCLUSION:

Our findings suggest that simultaneous infection with high- and low-risk HPV may reduce the risk of cervical malignancy.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Infect Disord Drug Targets Assunto da revista: DOENCAS TRANSMISSIVEIS / TERAPIA POR MEDICAMENTOS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Infect Disord Drug Targets Assunto da revista: DOENCAS TRANSMISSIVEIS / TERAPIA POR MEDICAMENTOS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Irã